RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES

Clinical trials for RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES explained in plain language.

Never miss a new study

Get alerted when new RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES trials appear

Sign up with your email to follow new studies for RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 2 Completed 1

New hope for leukemia patients after standard treatment fails

Disease control Completed

This early-stage study tested the safety and best dose of a two-drug combination (venetoclax and omacetaxine) for adults with acute myeloid leukemia (AML). The trial was for patients whose cancer had returned or stopped responding to a previous treatment that included venetoclax.…

Matched conditions: RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES

Phase: PHASE1 • Sponsor: University of Illinois at Chicago • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES

Get alerted when new RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES trials appear

New hope for leukemia patients after standard treatment fails